Skip to main content
Teaser
Kapseln
Teaser
Teaser

GMP Chitosan, medical device chitosan, pure chitin, pharma chitosan, chitosan derivatives, GMP, Quality, producer | Heppe Medical Chitosan

Written on .

Chitosan microparticles for the treatment of HIV-1 infection

Small interferring RNAs (siRNAs) can inactivate viruses by so-called gene silencing. In order to use this process in biomedicine, the transport of unstable siRNAs must be improved. In the presented study, siRNAs are coupled to chitosan microparticles and investigated for the inactivation of viral proteins in HIV-1 infected C8166 cells. siRNA transfection mediated by chitosan microparticles for the treatment of HIV-1 infections of human cell lines

Congress and fairs

Meet us in person 2025:

  • EPNOE - International Polysaccharide Conference, Sundsvall, Sweden, 25. - 28. August 2025
  • APCCS - Asia-Pacific Chitin and Chitosan Symposium, Taipei, Taiwan, 26. - 29. August 2025 
  • CPHI - Frankfurt, Germany, 28. - 30. October 2025
  • MEDICA - Düsseldorf, Germany, 17. - 20. November 2025

To arrange an appointment please contact Katja Richter via This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok
More information